CPF Texas’s Pfizer PFE Stock Holding History

CPF Texas’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1.67M	Buy	40,034 +28	+0.1%	+$1.08K	0.8%	42
2018 Q2	$1.38M	Sell	40,006 -1,104	-3%	-$37.7K	0.73%	43
2018 Q1	$1.38M	Buy	41,110 +18,350	+81%	+$631K	0.71%	42
2017 Q4	$782K	Buy	+22,760	New	+$776K	0.38%	66

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CPF Texas's PFE Position: Q3 2018 in Review

CPF Texas increased its Pfizer (PFE) stake by 0.07% in Q3 2018, buying an estimated $1.08K and bringing the position to 40,034 shares worth $1.67M. The position accounts for 0.8% of the portfolio, ranked #42.

CPF Texas first reported a position in PFE in Q4 2017 and has held it in 4 quarters since. 2,257 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

CPF Texas held 40,034 shares of Pfizer worth $1.67M as of Q3 2018.
CPF Texas bought 28 Pfizer shares in Q3 2018, an estimated $1.08K.
Pfizer made up 0.8% of CPF Texas's portfolio in Q3 2018, its #42 holding.
CPF Texas first reported a position in Pfizer in Q4 2017 and has held it in 4 quarters since.
2,257 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on CPF Texas's 13F filing for Q3 2018, filed 14 Nov 2018.